Mechanism for platelet reduction in anti-neuropilin-1 (MNRP1685A)–treated phase I patients. This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I. This abstract does not include a full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback